# Trop2-targeted immunoPET Imaging of Solid Tumors

Source: https://onco.cc/trials/nct06851663/  
OnCo record `nct06851663` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2/3 trial in lung cancer, run by RenJi Hospital, now recruiting.

## Summary

Trop2-targeted immunoPET Imaging of Solid Tumors. ClinicalTrials.gov record last updated 2026-05-29: recruiting. Enrollment is planned at 400 participants. Primary completion is estimated at 2027-12. No tabular results are posted on ClinicalTrials.gov; this does not exclude separate publications. Registered interventions: [68Ga]Ga-NOTA-T4, [68Ga]Ga-NOTA-RT4, [18F]F-RESCA-T4, [18F]F-RESCA-RT4. Registered primary measures: Biodistribution-Standardized uptake value (SUV) of normal tissues and organs.; SUV of tumors; Radiation dosimetry of tissues/organs.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-10-06
- Tags: ctgov-ingest; lung-deep-dive
- Registry id: NCT06851663
- Phase: 2/3
- Setting: Trop2-targeted immunoPET Imaging of Solid Tumors
- Sponsor: RenJi Hospital
- Enrolled: 400

## Notes

- ClinicalTrials.gov record last updated 2026-05-29: recruiting. Enrollment is planned at 400 participants. Primary completion is estimated at 2027-12. No tabular results are posted on ClinicalTrials.gov; this does not exclude separate publications.

## Sources

- ClinicalTrials.gov NCT06851663: https://clinicaltrials.gov/study/NCT06851663

## Connected records

- cancers: [Lung cancer (all types)](https://onco.cc/cancers/lung-cancer/)
- targets: [TROP2](https://onco.cc/targets/trop2/)
- terms: [Lung cancer trials open today (registry snapshot)](https://onco.cc/terms/lung-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06851663.json